TRANSFECTION WITH A CDNA-ENCODING A SER(31) OR SER(34) MUTANT HUMAN DIHYDROFOLATE-REDUCTASE INTO CHINESE-HAMSTER OVARY AND MOUSE MARROW PROGENITOR CELLS CONFERS METHOTREXATE RESISTANCE
D. Banerjee et al., TRANSFECTION WITH A CDNA-ENCODING A SER(31) OR SER(34) MUTANT HUMAN DIHYDROFOLATE-REDUCTASE INTO CHINESE-HAMSTER OVARY AND MOUSE MARROW PROGENITOR CELLS CONFERS METHOTREXATE RESISTANCE, Gene, 139(2), 1994, pp. 269-274
Chinese hamster ovary (CHO) DHFR(-) cells were converted into the DHFR
(+) phenotype when they were transfected with a mammalian expression v
ector carrying human dihydrofolate reductase-encoding cDNAs (DHFR) con
taining a Ser(31) or a Ser(34) mutation. Furthermore, transfection of
these mutants into wild-type CHO cells resulted in resistance to high
levels of methotrexate (MTX), indicating that these human variants can
act as dominant selectable markers. Southern blot analysis and polyme
rase chain reaction amplifications confirmed that the transfected plas
mids were integrated into the CHO DNA. Gene copy number analysis revea
led that both the Ser(31) and the Ser(34) mutants are amplifiable when
grown in increasing concentrations of MTX. Retrovirus-mediated gene t
ransfer of the Ser(31) mutant into mouse marrow progenitor cells also
resulted in MTX-resistant CFU-GM (colony-forming unit-granulocyte macr
ophage) cells.